Steven K. H. Foung

Stanford University — United States

Medicine · Health Sciences

58h-index10.2kcitations183works7.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(98), Monoclonal and Polyclonal Antibodies Research(89), Hepatitis B Virus Studies(71), T-cell and Retrovirus Studies(30), Animal Disease Management and Epidemiology(24)

Publications183 total

Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers
Communications Biology·2025· 2 citedOpen Access
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
Nature Communications·2024· 11 citedOpen Access
Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone
Journal of Hepatology·2024· 8 citedOpen Access
Joint statement in support of hepatitis C human challenge studies
˜The œLancet. Gastroenterology & hepatology·2023· 4 citedOpen Access
Hepatitis E virus seropositivity in an ethnically diverse community blood donor population
Vox Sanguinis·2023· 3 citedOpen Access
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate
Proceedings of the National Academy of Sciences·2022· 20 citedOpen Access
Editorial overview: Engineering elimination of chronic viral hepatitis
Current Opinion in Virology·2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development
Gastroenterology·2021· 41 citedOpen Access
Structural perspectives on HCV humoral immune evasion mechanisms
Current Opinion in Virology·2021· 20 citedOpen Access
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer
Proceedings of the National Academy of Sciences·2021· 34 citedOpen Access
Crystal Structure of a Bivalent Antibody Fab Fragment
Journal of Molecular Biology·2020· 5 cited
Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
UNC Libraries·2020Open Access
Human Monoclonal Antibodies and Immune Modulation in Viral Hepatitis, Schistosomiasis, and HTLV Infection
2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization
Journal of Virology·2020· 33 citedOpen Access
Human Monoclonal Autoantibodies
2020
An alternate conformation of HCV E2 neutralizing face as an additional vaccine target
Science Advances·2020· 42 citedOpen Access
SARS-CoV-2 RNAemia in a Healthy Blood Donor 40 Days After Respiratory Illness Resolution
Annals of Internal Medicine·2020· 23 citedOpen Access
Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization
2020· 3 citedOpen Access
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design
PLoS Pathogens·2019· 59 citedOpen Access
Interferon‐Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection
Hepatology·2019· 22 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Zhen–Yong Keck(24), Arvind H. Patel(11), Jinming Xia(8), Patrick Lau(8), Thomas F. Baumert(7), Zhen‐Yong Keck(6), Kenneth G. Hadlock(6), Jens Bukh(5), Jean Dubuisson(5), Thomas Krey(5), F.A. Rey(5), Ania M. Owsianka(5), Brian G. Pierce(5), Catherine Fauvelle(5), François–Loïc Cosset(4), Jannick Prentoe(4), Mirjam B. Zeisel(4), Thomas Pietschmann(4), Jane A. McKeating(4), Jeroen Witteveldt(4)